Prostate cancer drug combo gets a formulation Check-Up
NCT ID NCT04577833
First seen Oct 31, 2025 · Last updated May 09, 2026 · Updated 21 times
Summary
This study looks at how well the body absorbs different versions of two prostate cancer drugs, niraparib and abiraterone acetate, in men with advanced prostate cancer that no longer responds to hormone therapy. About 136 men will take the drugs in different forms and sequences to compare their absorption. The goal is to find the best formulation for future use, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARENSIA Exploratory Medicine Unit
Kyiv, 01135, Ukraine
-
Arensia Exploratory Medicine
Chisinau, Md2025, Moldova
-
Arensia Exploratory Medicine 1
Tbilisi, 0112, Georgia
-
Erasmus MC
Rotterdam, 3015 GD, Netherlands
-
GZA Ziekenhuizen- Campus St Augustinus
Wilrijk, 2610, Belgium
-
HIA Begin
Saint-Mandé, 94163, France
-
Hosp Univ Fund Jimenez Diaz
Madrid, 28040, Spain
-
Hosp Univ Hm Sanchinarro
Madrid, 28050, Spain
-
Hosp Virgen de La Victoria
Málaga, 29010, Spain
-
Institut Bergonié, Centre de Lutte Contre le Cancer
Bordeaux, 33000, France
-
Karolinska Universitetssjukhuset Solna
Stockholm, 171 76, Sweden
-
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
Warsaw, 02-781, Poland
-
START Mountain Region
West Valley City, Utah, 84119, United States
-
Sir Bobby Robson Unit, Northern Centre for Cancer Care
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Uniwersyteckie Centrum Kliniczne
Gdansk, 80 214, Poland
Conditions
Explore the condition pages connected to this study.